According to the Clarivate Journal Citation Reports (JCR) released in June 2025, the official 2024 impact factor for Computers in Biology and Medicine is 6.3.
Computers in Biology and Medicine (CBM) is an international, peer‑reviewed journal published by Elsevier. It began in 1970 and is released monthly, covering the interface of computing and life sciences. According to ScienceDirect’s journal description, CBM focuses on biomedical engineering, computational biology, bioinformatics, and computer science applied to healthcare. It publishes research articles, reviews, tutorials and letters on how computer tools solve problems in medicine and biology. In short, CBM is a well-established journal for biomedical computing research.
Read more papers published in Computers in Biology and Medicine
Elsevier publishes the Computers in Biology and Medicine journal, and it specializes in research on computing applications in healthcare and biosciences.
The journal’s scope includes topics like medical image analysis, simulation of biological systems, medical informatics, genomics, proteomics, and more. For example, the journal’s own descriptions highlight advances in areas such as real-time clinical data processing, bioinformatics and even early internet-based medical applications. In other words, CBM is a broad platform bridging the “two worlds” of computing and life science.
Over the years, thousands of researchers have published studies involving machine learning for diagnosis, genomic sequence analysis, and computer vision for pathology images – all within CBM’s broad but targeted remit.
CBM has a rich history. It first launched in August 1970 (Volume 1, Issue 1) and has maintained monthly publication ever since. It has been indexed in MEDLINE/PubMed from its very first issue, ensuring visibility for all articles published over the last 50+ years.
Topics like artificial intelligence and pattern recognition have become increasingly central in recent years. A bibliometric review from 2023 identified AI as the leading subject among CBM articles, reflecting the journal’s responsiveness to evolving scientific focus areas.
Wondering why that matters? Because CBM doesn’t just publish conventional modeling. From simulating heart mechanics to interpreting retinal images using convolutional neural networks, the journal consistently attracts work that connects computational innovations with pressing medical problems.
2024 Computers in Biology and Medicine Impact FactorOfficial Impact Factor: 6.3
According to the Clarivate Journal Citation Reports (JCR) released in June 2025, the official 2024 impact factor for Computers in Biology and Medicine is 6.3.
Metric | Value |
---|---|
Official Impact Factor (JCR 2024) | 6.3 |
SJR (Scopus 2024) | 1.447 (Q1 across key fields) |
CiteScore (Scopus 2023) | ~13.0 |
Citations per Document (Scopus) | ~8.98 (2024 average) |
H‑Index | ~142 |
Publication Frequency | Monthly (12 issues/year) |
If you’d like help comparing Computers in Biology and Medicine to peer journals like Bioinformatics, IEEE Journal of Biomedical and Health Informatics, or revising content or SEO elements accordingly, I’d be happy to assist further!
Explore more recent papers: Computers in Biology and Medicine
Yes. CBM is indexed in all leading databases, including MEDLINE/PubMed, Science Citation Index Expanded (SCIE), Scopus, and EMBASE.
According to SCImago Journal Rank, CBM ranks in Q1 (top 25%) for Health Informatics and Computer Science – Applications. In 2024, its SJR score is 1.447, placing it squarely in the upper echelon of journals in both technical and biomedical domains.
The National Library of Medicine confirms that CBM has been included in MEDLINE since its inception in 1970 – a rare distinction that reflects long-term credibility.
Here’s a helpful analogy: Think of journal quartiles like school grades. A Q1 journal is an “A-level” journal. So CBM is essentially an A student in its class. It’s often used as a benchmark by universities and authors when choosing where to publish.
University rankings, grant review boards, and tenure committees often rely on quartile data when assessing journal quality. Being Q1 in dual disciplines gives CBM an edge in the highly competitive publication landscape.
Because CBM reflects the intersection of computation and clinical need, it’s become a go-to journal for researchers in health-tech and life sciences.
As recent reviews confirm, machine learning, AI, and data-driven diagnostics dominate the journal’s most cited articles. That mirrors global trends: big data and AI in healthcare are booming, and CBM captures that wave with surprising consistency.
If you’re a researcher using Python to model protein folding or building neural networks to segment CT scans, CBM is likely where your peers are publishing – and reading.
CBM’s appeal also lies in its dual purpose: it’s rigorous and readable. In addition to technical research, the journal offers tutorials and reviews that help new researchers (or interdisciplinary teams) catch up with emerging methods.
Platforms like PubMed.ai are particularly helpful here. You can track CBM’s most-cited papers, citation trends, and related journals in seconds. This blog, for instance, lives on PubMed.ai – a curated discovery platform for biomedical publishing.
Want faster, smarter access to biomedical research?
Let PubMed.ai be your AI-powered research assistant — it helps you search, summarize, and analyze biomedical papers with ease. Think of it as your personal co-pilot for navigating the literature.
Read more:
The abbreviation is Comput. Biol. Med. The print ISSN is 0010-4825 and the online ISSN is 1879-0534.
CBM is a monthly journal. You can expect about 12 issues per year, typically published regularly each month.
Yes, CBM is peer-reviewed. It publishes original research, review articles, tutorials, editorials and letters on computational methods in biology and medicine. Typical topics include biomedical data analysis, medical informatics, computational genomics, and related areas.
You can access articles through ScienceDirect, or search summaries via PubMed.ai.
Have a question about medical research, clinical practice, or evidence-based treatment? Access authoritative, real-time insights: PubMed.ai is an AI-Powered Medical Research Assistant.